Allosteric Modulation of the Activity of the Glucagon-like Peptide-1 (GLP-1) Metabolite GLP-1 9–36 Amide at the GLP-1 Receptor

@inproceedings{Li2012AllostericMO,
  title={Allosteric Modulation of the Activity of the Glucagon-like Peptide-1 (GLP-1) Metabolite GLP-1 9–36 Amide at the GLP-1 Receptor},
  author={Naichang Li and Jing Hua Lu and Gary B. Willars},
  booktitle={PloS one},
  year={2012}
}
Glucagon-like peptide-1 (GLP-1) released from intestinal L cells in response to nutrients has many physiological effects but particularly enhances glucose-dependent insulin release through the GLP-1 receptor (GLP-1R). GLP-1 7-36 amide, the predominant circulating active form of GLP-1, is rapidly truncated by dipeptidyl peptidase-4 to GLP-1 9-36 amide, which is generally considered inactive. Given its physiological roles, the GLP-1R is targeted for treatment of type 2 diabetes. Recently… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 13 CITATIONS

GLP-1(28-36)amide, a Long Ignored Peptide Revisited

  • The open biochemistry journal
  • 2014
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 43 REFERENCES

Small-molecule agonists for the glucagon-like peptide 1 receptor.

  • Proceedings of the National Academy of Sciences of the United States of America
  • 2007
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

The structure and function of the glucagon-like peptide-1 receptor and its ligands

D Donnelly
  • Br J Pharmacol
  • 2012

Similar Papers

Loading similar papers…